Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00279916 · ClinicalTrials.gov registry record · Phase 3

Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays

A Phase 3 study of Otitis Media With Effusion and Rhinitis, sponsored by Mayo Clinic.

Completed
Registry status
Phase 3
Development phase
91
Enrollment target
1
Study location

NCT00279916 is a Phase 3 study of Otitis Media With Effusion and Rhinitis that has completed, run by Mayo Clinic. The registered enrollment target is 91 participants, below the 178-participant average among 5 other Otitis Media With Effusion trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00279916, a Phase 3 study of Otitis Media With Effusion and Rhinitis, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 3
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

We hypothesize that intranasal steroid application will have a beneficial therapeutic effect in adults with regard to resolution of serous otitis media and/or negative middle ear pressure, as compared to placebo. We further hypothesize that the rate of spontaneous short-term resolution of otitis media wit effusion in adults treated with placebo will be relatively low (minority of patients).

Interventions

  • DRUG Placebo nasal spray
  • DRUG Triamcinolone acetonide nasal spray

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2005-09-01
Est. Completion 2009-03
Phase Phase 3

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT00279916

The ClinicalTrials.gov registry entry for NCT00279916 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 5 other Otitis Media With Effusion trials with a reported enrollment target (49% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Otitis Media With Effusion appearing as the primary indexed condition, and to 2 interventions - of which Placebo nasal spray is the first listed.

NCT00279916 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT00279916 about?

NCT00279916 is a clinical study titled "Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays". We hypothesize that intranasal steroid application will have a beneficial therapeutic effect in adults with regard to resolution of serous otitis media and/or negative middle ear pressure, as compared to placebo. We further hypothesize that the rate of spontaneous short-term resolution of otitis med...

What is the current status of trial NCT00279916?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 91 participants. The study started on 2005-09-01. Estimated completion is 2009-03.

What conditions does trial NCT00279916 study?

This clinical trial studies the following conditions: Otitis Media With Effusion, Rhinitis, Otitis Media, Serous, Negative Middle Ear Pressure, Otitis Media, Secretory.

What interventions are being tested in trial NCT00279916?

The interventions under investigation include: Placebo nasal spray (DRUG), Triamcinolone acetonide nasal spray (DRUG).

Who is sponsoring clinical trial NCT00279916?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00279916 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Otitis Media With Effusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.